Tag: Cancer: Cervical
1.3 Million Older Women Still Receive Cervical Cancer Screening-Related Services
In 2019, Medicare fee-for-services spent $83.5 million on these potentially unnecessary services
Cervical Cancer Incidence Up Among Women Ages 30 to 34 Years
Findings similar across most races and cancer stages from 2012 to 2019
ASTRO: Sexual Function After Brachytherapy Less Often Assessed in Women
Sexual function less likely to be assessed in women versus men undergoing brachytherapy for genitourinary cancers
Black Women Have Increased Rates of Distant-Stage Cervical Cancer
However, White women in South aged 40 to 44 years have highest annual increase in distant-stage cervical cancer at rate of 4.5 percent
HPV Vaccination May Cut Risk for CIN2+ Recurrence
Effect estimate stronger for CIN2+ for disease related to HPV subtypes HPV 16 or HPV 18
Breast, Cervical Cancer Screening Decreased From 2018 to 2020
Prevalence of CRC screening remained stable with increase in stool testing offsetting decrease in colonoscopy
Sexual Minority Status Linked to Lower Odds of Pap Screen
Odds of ever undergoing pap testing lower for non-Hispanic White and Hispanic SM participants versus non-Hispanic White heterosexuals
Patient-Reported Outcomes + Wearable Data Predict Postop Adverse Events
Findings seen among women with gynecologic cancers followed for four weeks
Cemiplimab Prolongs Survival in Recurrent Cervical Cancer
Overall survival longer with cemiplimab versus single-agent chemo for recurrent disease after first-line platinum-containing chemo
Adverse Pregnancy Outcomes Reported for Women Diagnosed With CIN 3
Risk differences for all outcomes were attenuated over time; risk for early neonatal death disappeared
